PL3269721T3 - Bicykliczny związek pirydynowy - Google Patents

Bicykliczny związek pirydynowy

Info

Publication number
PL3269721T3
PL3269721T3 PL15884684T PL15884684T PL3269721T3 PL 3269721 T3 PL3269721 T3 PL 3269721T3 PL 15884684 T PL15884684 T PL 15884684T PL 15884684 T PL15884684 T PL 15884684T PL 3269721 T3 PL3269721 T3 PL 3269721T3
Authority
PL
Poland
Prior art keywords
pyridine compound
bicyclic pyridine
bicyclic
compound
pyridine
Prior art date
Application number
PL15884684T
Other languages
English (en)
Inventor
Kenichi Kawaguchi
Akihiro ISHIHATA
Akira Kanai
Yusuke INAGAKI
Masashi Hiramoto
Kentaro Enjo
Hajime Takamatsu
Original Assignee
Astellas Pharma Inc.
Kotobuki Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc., Kotobuki Pharmaceutical Co., Ltd. filed Critical Astellas Pharma Inc.
Publication of PL3269721T3 publication Critical patent/PL3269721T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4355Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PL15884684T 2015-03-09 2015-11-27 Bicykliczny związek pirydynowy PL3269721T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015046121 2015-03-09
EP15884684.0A EP3269721B1 (en) 2015-03-09 2015-11-27 Bicyclic pyridine compound
PCT/JP2015/083345 WO2016143200A1 (ja) 2015-03-09 2015-11-27 二環式ピリジン化合物

Publications (1)

Publication Number Publication Date
PL3269721T3 true PL3269721T3 (pl) 2021-10-11

Family

ID=56880128

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15884684T PL3269721T3 (pl) 2015-03-09 2015-11-27 Bicykliczny związek pirydynowy

Country Status (23)

Country Link
US (1) US10023583B2 (pl)
EP (1) EP3269721B1 (pl)
JP (1) JP6646648B2 (pl)
KR (1) KR102446212B1 (pl)
CN (1) CN107428768B (pl)
AR (1) AR102849A1 (pl)
AU (1) AU2015386039B2 (pl)
BR (1) BR112017018649B8 (pl)
CA (1) CA2976746C (pl)
CO (1) CO2017008372A2 (pl)
ES (1) ES2869924T3 (pl)
IL (1) IL254307B (pl)
MX (1) MX370920B (pl)
MY (1) MY198083A (pl)
PH (1) PH12017501596B1 (pl)
PL (1) PL3269721T3 (pl)
PT (1) PT3269721T (pl)
RU (1) RU2700411C2 (pl)
SG (1) SG11201706745PA (pl)
TW (1) TWI700285B (pl)
UA (1) UA121889C2 (pl)
WO (1) WO2016143200A1 (pl)
ZA (1) ZA201706038B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210369654A1 (en) 2018-10-16 2021-12-02 Nippon Chemiphar Co., Ltd. Agent for improving quality of sleep
EP3868370A4 (en) 2018-10-17 2022-06-29 Nippon Chemiphar Co., Ltd. Therapeutic or prophylactic agent for nocturia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2403340T3 (es) 2004-09-09 2013-05-17 Howard Florey Institute Of Experimental Physiology And Medicine Inhibidores de aminopeptidasa regulada por insulina (IRAP) y usos de los mismos
EA015127B1 (ru) * 2006-06-08 2011-06-30 Эли Лилли Энд Компани Антагонисты мсн-рецепторов
EP2262797A4 (en) 2007-11-19 2011-11-30 Howard Florey Inst INHIBITORS OF INSULIN REGULATED AMINO PEPTIDASE (IRAP) AND APPLICATIONS THEREOF
JPWO2010053120A1 (ja) 2008-11-06 2012-04-05 アステラス製薬株式会社 カルバメート化合物又はその塩
JP2013147430A (ja) * 2010-04-28 2013-08-01 Astellas Pharma Inc 夜間頻尿の予防又は治療剤
RS54834B1 (sr) * 2010-09-07 2016-10-31 Astellas Pharma Inc Jedinjenja pirazolokvinolina
WO2014011906A2 (en) * 2012-07-11 2014-01-16 Nimbus Iris, Inc. Irak inhibitors and uses thereof
TWI647227B (zh) 2013-02-28 2019-01-11 日商安斯泰來製藥股份有限公司 2-醯胺噻唑衍生物或其鹽
WO2015182686A1 (ja) * 2014-05-28 2015-12-03 アステラス製薬株式会社 ピリジン誘導体

Also Published As

Publication number Publication date
US10023583B2 (en) 2018-07-17
CN107428768A (zh) 2017-12-01
MY198083A (en) 2023-07-31
BR112017018649B1 (pt) 2023-07-11
BR112017018649A2 (pt) 2018-04-17
MX2017010930A (es) 2018-01-23
MX370920B (es) 2020-01-09
JP6646648B2 (ja) 2020-02-14
CO2017008372A2 (es) 2017-11-30
WO2016143200A1 (ja) 2016-09-15
EP3269721A4 (en) 2018-08-01
KR20170124531A (ko) 2017-11-10
JPWO2016143200A1 (ja) 2018-02-08
PH12017501596A1 (en) 2018-02-12
RU2700411C2 (ru) 2019-09-17
TW201636352A (zh) 2016-10-16
EP3269721A1 (en) 2018-01-17
CA2976746A1 (en) 2016-09-15
ZA201706038B (en) 2019-01-30
ES2869924T3 (es) 2021-10-26
PT3269721T (pt) 2021-05-05
IL254307A0 (en) 2017-11-30
US20180022755A1 (en) 2018-01-25
CN107428768B (zh) 2020-09-18
UA121889C2 (uk) 2020-08-10
IL254307B (en) 2020-11-30
AU2015386039B2 (en) 2020-05-07
EP3269721B1 (en) 2021-04-07
BR112017018649B8 (pt) 2023-10-03
SG11201706745PA (en) 2017-09-28
CA2976746C (en) 2023-01-24
RU2017134316A (ru) 2019-04-03
TWI700285B (zh) 2020-08-01
PH12017501596B1 (en) 2018-02-12
AR102849A1 (es) 2017-03-29
AU2015386039A1 (en) 2017-08-10
RU2017134316A3 (pl) 2019-04-24
KR102446212B1 (ko) 2022-09-22

Similar Documents

Publication Publication Date Title
IL261551B (en) bicyclic compounds
ZA201902232B (en) Pyridine compound
IL255357A0 (en) bicyclic compounds
ZA201805210B (en) Azole-substituted pyridine compound
ZA201701210B (en) Substituted bicyclic compounds
IL258952B (en) A pyranodipyridine compound
GB201521524D0 (en) Compound
ZA201701783B (en) Pyridine compounds
DK3330264T3 (en) Pyridin substitueret 2-aminopyridin proteinkinase-inhibitorkrystal
ZA201706038B (en) Bicyclic pyridine compound
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
GB201518950D0 (en) Compound
ZA201801098B (en) Tetrahydrooxepinopyridine compound
GB201520393D0 (en) Compound
GB201520391D0 (en) Compound
GB201509303D0 (en) Compound
GB201508453D0 (en) Compounds
GB201505675D0 (en) Compounds
GB201505676D0 (en) Compounds
GB201505670D0 (en) Compounds
GB201505674D0 (en) Compounds
GB201503726D0 (en) Compounds